Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06259916 · ClinicalTrials.gov registry record · NA
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
A NA study of Cannabis Use and Alcohol Use, Unspecified, sponsored by Colorado State University.
- Recruiting
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT06259916: Recruiting NA study of Cannabis Use and Alcohol Use, Unspecified, sponsored by Colorado State University.
NCT06259916 is a NA study of Cannabis Use and Alcohol Use, Unspecified that is actively recruiting participants, run by Colorado State University. The registered enrollment target is 99 participants, below the 277-participant average among 44 other Cannabis Use trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06259916, a NA study of Cannabis Use and Alcohol Use, Unspecified, is actively recruiting participants, sponsored by Colorado State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, parallel-group study designed to explore the differences between cannabis intoxication, alcohol intoxication and co-intoxication involving both alcohol and cannabis, utilizing electroencephalography (EEG) as well as more traditional intoxication measures such as breath alcohol concentration and balance metrics. If eligible for the study, participants will be randomized to complete one study session in our mobile laboratory, during which they will use either alcohol, cannabis (which will be self-administered, ad libitum) or both alcohol and cannabis.
Primary Outcome
The EEG amplitude (measured in microvolts) will be obtained while participants perform the speeded visual flanker task
Conditions Studied
Interventions
- OTHER Alcohol
- OTHER Cannabis
Study Locations (1)
Colorado
- Colorado State University - Fort Collins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2024-01-05 |
| Est. Completion | 2026-05-30 |
| Phase | NA |
What NCT06259916 shows while recruiting
NCT06259916 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 277-participant average among 44 other Cannabis Use trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Cannabis Use appearing as the primary indexed condition, and to 2 interventions - of which Alcohol is the first listed.
NCT06259916 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06259916 about?
NCT06259916 is a clinical study titled "Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)". This is a randomized, parallel-group study designed to explore the differences between cannabis intoxication, alcohol intoxication and co-intoxication involving both alcohol and cannabis, utilizing electroencephalography (EEG) as well as more traditional intoxication measures such as breath alcohol ...
What is the current status of trial NCT06259916?
This trial is currently recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2024-01-05. Estimated completion is 2026-05-30.
What conditions does trial NCT06259916 study?
This clinical trial studies the following conditions: Cannabis Use, Alcohol Use, Unspecified.
What interventions are being tested in trial NCT06259916?
The interventions under investigation include: Alcohol (OTHER), Cannabis (OTHER).
Who is sponsoring clinical trial NCT06259916?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06259916 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06259916's enrollment target sits among peer trials
99 26th of 44 higher than 19 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
RECRUITING · NA
-
Stress and Resilience
RECRUITING · NA
-
Perceptual Influences From Smoking Cannabis: an Experimental Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI